Occam Places Bell Zhong as CFO at Neomorph
Neomorph, an induced proximity platform company which raised a $109 Million A round led by Deerfield, has added Bell Zhong as Chief Financial Officer.
Neomorph is focused on solving critical problems in human health through the discovery and development of innovative new medicines against “undruggable targets.”
Zhong brings nearly two decades of investment banking and corporate finance leadership experience in the healthcare and life sciences sector. Bell joins Neomorph from Raymond James where he was Managing Director covering the biotechnology sector, responsible for advising companies of all stages of development on a wide array of financing and strategic transactions. Previously, Bell spent over 13 years at J.P. Morgan, where most recently he served as Executive Director in the firm’s leading Healthcare Investment Banking practice.
Recent Placements
Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.